Trial
NCT04925947
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Condition
Thymic Carcinoma
Intervention
KN046
Why stopped
Data collected did not support the study endpoints
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-16